Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ digital
    • Subscribe to CMAJ print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ digital
    • Subscribe to CMAJ print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
News

Repeated flu shots may blunt effectiveness

Terry Murray
CMAJ April 07, 2015 187 (6) E180; DOI: https://doi.org/10.1503/cmaj.109-5000
Terry Murray
Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Universal influenza immunization programs, available in virtually every province and territory, may need to be reconsidered in light of emerging evidence that repeated flu shots may blunt the vaccine’s effectiveness in subsequent seasons.

That phenomenon was seen in the Jan. 29, 2015 interim estimates of the effectiveness of the 2014/15 vaccine against influenza A (H3N2) from Canada’s Sentinel Physician Surveillance Network, headed by Dr. Danuta Skowronski of the British Columbia Centre for Disease Control.

The effects of repeat immunizations need to be studied further. Meanwhile, a return to targeted, high-risk flu vaccine programs, rather than universal coverage, seems warranted, said Skowronski, the BC centre’s epidemiology lead for influenza and emerging respiratory pathogens.

At the same time, antivirals — formerly plan B in the primary prevention of influenza — should be used early. “There’s a lot of debate about antivirals and that needs to be resolved also, but for now, [early antiviral use] should come to the fore,” Skowronski said.

The BC network’s estimates of this year’s flu vaccine efficacy, published in Eurosurveillance, were −8% overall and 2% in young adults against medically attended, laboratory-confirmed influenza A (H3N2) infection — which Skowronski said she interprets as a null effect. This also represents the lowest measured protection against a seasonal virus in the program’s 10-year history, she added.

It recently became known that this year’s H3N2 virus was not a match for the H3N2 component of this year’s trivalent vaccine, but the authors of this new study also saw variability in vaccine effectiveness that was related to prior vaccination history. Vaccine effectiveness was 43% for those who hadn’t received the 2013/14 vaccine but −15% for participants who received both seasons’ vaccines.

Those are not statistically significant findings, “but when you’re dealing with a low vaccine effectiveness, even 40%, and a null effect in those who received vaccine the previous year, you need a massive sample size to prove that statistically,” Skowronski said. “If we wait for that we’ll never be able to tease apart these signals.”

Figure

Research in both Canada and the US indicates that getting the flu shot several years in a row may lessen the vaccine’s effectiveness.

Image courtesy of Mario Tamo/iStock/Thinkstock

Dr. Richard Schabas, Ontario’s former chief medical officer who is now medical officer of health in the Hastings and Prince Edward Counties Health Unit in Belleville, Ontario, agrees that it’s time to revisit universal flu vaccine programs, which are now available in all Canadian provinces and territories except BC, Quebec and New Brunswick.

He was once a proponent of universal programs but now says, “We should use the next six months or so to do a very careful rethink of where we are. There’s enough new evidence that we should all be troubled enough by, that we should be taking a long and sober look at our policies. There are more and more unanswered questions about how effective a universal program really is.”

Canada’s Sentinel Physician Surveillance Network has previously observed this decrease in effectiveness, as have others. In the September 2014 issue of Clinical Infectious Diseases, US investigators documented a lower vaccine effectiveness in those who’d had flu vaccine over the previous five years, compared to those who’d had only the previous year’s vaccine or no vaccine previously.

The findings are also consistent with a 1999 observation of variable flu vaccine efficacy depending on immunization history, by Derek J. Smith, the current director, WHO Collaborating Centre for Modelling, Evolution and Control of Emerging Infectious Diseases. Smith proposes “antigenic distance” as an explanation. This hypothesis holds that the impact on the current season’s vaccine effectiveness is most pronounced when the difference between last season’s vaccine component and the current season’s vaccine component is small (this year they’re identical).

In that case, the current season’s vaccine may boost memory of the earlier vaccine’s antibody responses; then these “old” antibodies may mop up the current vaccine’s antigen before the newly vaccinated person can mount an immune response to it (this is called antibody interference).

For now, researchers need to investigate the phenomenon, Skowronski said. And public health officials need to reconsider the wisdom of targeted flu vaccine programs, especially in a year when the elderly have been disproportionately affected.

On Feb. 5, 2015, other Canadian researchers published interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalization. The figure for people aged 65 and over was −32.9%, according to findings from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 187 (6)
CMAJ
Vol. 187, Issue 6
7 Apr 2015
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Repeated flu shots may blunt effectiveness
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Repeated flu shots may blunt effectiveness
Terry Murray
CMAJ Apr 2015, 187 (6) E180; DOI: 10.1503/cmaj.109-5000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Repeated flu shots may blunt effectiveness
Terry Murray
CMAJ Apr 2015, 187 (6) E180; DOI: 10.1503/cmaj.109-5000
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Saying goodbye to CMAJ News
  • National survey highlights worsening primary care access
  • How Canadian hospitals are decreasing carbon emissions
Show more News

Similar Articles

Collections

  • Topics
    • Drugs: immunologic
    • Infectious diseases
    • Vaccination

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire